US Patent Issued to Amgen on April 22 for "Combination therapy including a KRAS G12C inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers" (California Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,280,056, issued on April 22, was assigned to Amgen Inc. (Thousand Oaks, Calif.).

"Combination therapy including a KRAS G12C inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers" was invented by James Russell Lipford (Thousand Oaks, Calif.), Jude Robert Canon (Newbury Park, Calif.), Anne Y. Saiki (Moorpark, Calif.) and Karen Louise Rex (Thousand Oaks, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides combination therapy that includes an KRASG12C inhibitor, such asor a pharmaceutically acceptable salt thereof, and one or more additional pharmaceutically active agents, particular...